The existence of subpopulations of clonal lymphocytes in patients with low grade lymphoproliferative disorders, with re-
a pre-B cell leukaemia cell line has been shown to block chemotherapy induced apoptosis.9 Successful treatment of low grade lymphoproliferative disorders with purine analogues (fludarabine, 2-chlorodeoxy-adenosine (2-CdA) and deoxycoformycin) is dependent on the induction of apoptosis in lymphocytes, hence there has been speculation as to whether the concentration of bcl-2 in lymphocytes could predict the outcome of treatment in these patients.
In the process of investigating bcl-2 in B cells of patients with lymphoproliferative disorders, we identified some patients with appreciable heterogeneity in cell size and bcl-2 concentration. Other investigators have noted the occurrence of a population of larger lymphocytes in some patients with chronic lymphocytic leukaemia and reported that these cells had significantly more nucleoside transporter protein than normal sized lymphocytes.10 These observations raise the possibility that these cells form a functionally distinct component of the underlying clonal population.
The bcl-2 protein has been shown to be overexpressed in low grade lymphoproliferative disorders. In follicular non-Hodgkin's lymphoma (NHL) 
levels of bcl-2. Fifteen of these patients had previously been treated and this observation can be explained by detection of the reemergence of the malignant clone against a background of normal cells; however, the other five patients were not in this situation with virtually all of their B cells being of clonal origin (as shown by surface immunophenotyping). The CD19+ lymphocytes in these patients all showed more intense staining than normal B cells with anti-bcl-2 (data not shown). In all cases the more intensely staining bcl-2 populations corresponded to a subset of larger lymphocytes and in three of the five cases these cells formed a separate population on staining with CD 19 (fig 1) .
Statistical analysis on one patient (DL) showed K' for linear regression of the square root of the forward scatter against the cube root of the green fluorescence to be 0.69 for the total cell population. When the cells were split into two populations on the basis of green fluorescence (high and low) (fig 1 B) and the regression repeated, R' for high was 0.04 and for low it was 0.33; suggesting that the relation between cell size and bcl-2 concentration does not persist within the subpopulations.
This patient was monitored during chemotherapy with 2-CdA, after just one course elimination of the high bcl-2 cells present before treatment was observed. This was followed by a reduction in the lower bcl-2 cells after further courses, accompanied by reemergence of a lymphocyte population showing a level of bcl-2 protein equivalent to that of normal lymphocytes (fig 2) . This re-emergence of normal B cells was supported by flow cytometric analysis of clonality. The disappearance of the high bcl-2 cells was also noted in two patients on treatment with chlorambucil and prednisolone, and in one patient not receiving any treatment.
Discussion
It is generally presumed that cells with a high bcl-2 concentration should be more resistant to chemotherapy induced apoptosis. The data presented here conflicts with this theory and raises the question of whether bcl-2 concentration in a cell is related to cell size. Little attention appears to have been given to assessing whether larger cells require more bcl-2 to achieve an equivalent anti-apoptotic effect. Consideration of antigens expressed on the cell surface is relatively straightforward-the larger the cell, the greater the surface area and therefore the higher the fluorescence intensity expected. However, bcl-2 is an intracellular protein so it is not obvious whether a similar argument should be applied. Other investigators assessing the prognostic significance of bcl-2 concentration in acute myeloid leukaemia compensated for size difference simply by dividing by mean These observations highlight the heterogeneity possible in clonal lymphocyte populations and raise a note of caution for techniques that, unlike flow cytometry, do not alert the user to this. A physiological difference is apparent between these subpopulations of lymphocytes that has not been fully explained by examination of cell size and levels of bcl-2 alone.
